Sequential versus concurrent adjuvant chemo-endocrine therapy for HR+ early breast cancer: a systematic review and Bayesian network meta-analysis.

Transl Breast Cancer Res · 2022 · PMC11093067 · PMID 38751511

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

Comparisons with HR <1, upper 95% CrI ≤1.05 or HR >1, lower 95% CrI ≥0.95 were considered marginal significance.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.